
Abstract The rise of multidrug‐resistant bacteria demands innovative antimicrobial strategies that combine multiple mechanisms of action. Selenium nanoparticles functionalized with 5‐aminolevulinic acid (ALASe) offer a dual‐action platform, coupling the intrinsic bactericidal activity of selenium with photodynamic toxicity derived from metabolically generated porphyrins. ALASe nanoparticles were synthesized via a one‐pot photoreduction method and characterized by TEM, DLS, XRD, FTIR, 1 H NMR, HRMS, ICP‐OES, and fluorescence spectroscopy. The resulting nanoparticles were spherical, 180–220 nm in size, with moderate colloidal stability (zeta potential ≈ −26 mV) and fluorescence emission at 514 nm. Antibacterial activity was evaluated against Escherichia coli and Staphylococcus aureus under dark and blue‐light (460 nm) conditions. ALASe exhibited dose‐dependent dark toxicity against both strains, confirming an intrinsic selenium‐mediated antibacterial effect. Upon blue‐light irradiation, bacterial inactivation was significantly enhanced, consistent with metabolic conversion of ALA into photoactive porphyrins. Intracellular porphyrin accumulation was confirmed by fluorescence spectroscopy, and photodynamic efficacy correlated directly with porphyrin levels. Singlet oxygen generation was further quantified by phosphorescence decay analysis of porphyrins extracted from ALASe‐incubated bacteria, confirming the photosensitizing role of the accumulated porphyrins. Together, these results demonstrate that ALASe combines two complementary antibacterial mechanisms: selenium‐dependent dark toxicity and a light‐activatable photodynamic response driven by bacterial conversion of ALA to porphyrin. This dual‐mechanism positions ALASe as a promising multifunctional nanoplatform for combating antibiotic‐resistant infections, particularly in superficial or topical applications where light delivery is feasible.
Abstract To evaluate the field performance of human‐occupied air disinfection strategies in high‐risk healthcare areas, field tests were conducted in the high‐risk triage area, infectious disease ward, and dental clinics of a top‐tier academic medical center. Existing air disinfection or ventilation‐based control measures, including plasma air disinfection devices, ultraviolet (UV) air cleaners, and negative‐pressure ventilation systems, were evaluated alone or in combination with a 222‐nm UV upper‐room air disinfection system. No air disinfection intervention was used in the control group. Air sampling was performed hourly during daytime clinical hours using a six‐stage impactor microbial sampling method or a settle plate method. Compared with no‐disinfection controls or existing‐measure comparators, airborne bacterial concentrations were generally lower in the 222‐nm UV group or 222‐nm UV add‐on groups across multiple clinical settings. Percentage reductions relative to valid comparators ranged from 48.04% to 73.74% for 222‐nm UV alone and from 6.86% to 73.77% for 222‐nm UV used as an add‐on to existing measures. These findings suggest that 222‐nm UV upper‐room air disinfection may reduce airborne bacterial concentrations and improve air hygiene quality under routine clinical conditions. Because the study was not designed to determine mechanistic synergy, observed reductions in combined‐use groups are presented as add‐on field performance rather than evidence of synergistic interaction.
Abstract Two new cationic BODIPY dyes have been synthesized and characterized. Methylation of the nitrogen‐atoms associated with the isoquino‐based BODIPY core provides water solubility via a high‐yield one‐step process. Dye 2 shows spectroscopic evidence of H‐aggregation, while dye 4 incorporates meso‐mesityl moieties, preventing aggregation and providing the expected intense absorption slightly shifted to higher energy compared to its neutral precursor BODIPY. Experimental evidence confirms that both dyes are capable of singlet oxygen production. The production of singlet oxygen is modest, with both dyes showing 21% yield as determined by spectroscopic studies with the singlet oxygen quencher DPBF. Photoreactions with plasmid DNA show the ability of these dyes to act as photosensitizers under physiological conditions. Although one of the dyes forms aggregates in solution, this does not appear to hinder its ability to act as a photosensitizer.
Abstract Sunlight ultraviolet radiation A and B (UV‐A and UV‐B) affect human skin and may be a cause of cancer. Damage to skin nerve fibers and cell DNA is often observed following excessive unprotected exposure. Plants produce numerous specialized metabolites involved in stress mitigation. Brachycerine, a major leaf glucoside alkaloid from the tree Psychotria brachyceras , absorbs in the UV range and is a powerful antioxidant protecting the photosynthetic machinery against this radiation. Herein, the protective effects of new skincare formulations containing brachycerine or foliar extract were tested on ex vivo human skin exposed to UV. Nerve fibers were identified by immunofluorescence, and UV damage or neuroprotection effects were assessed by image analysis. DNA integrity of UV‐B treated samples was evaluated by comet assays. UV‐A and UV‐B significantly reduced (circa 50%) the measured nerve endings density in the untreated or placebo‐treated samples. Pre‐treatment with tested skincare formulations completely blocked the effects of UV on nerve endings. UV‐B‐induced DNA damage was abolished by both the alkaloid and the extract. Cytotoxicity assays showed that brachycerine was not toxic to mammalian cells. Formulations with brachycerine or leaf extract effectively protected ex vivo human skin exposed to UV, indicating that these phytochemicals are potential candidate components of new broad spectrum natural sunscreens.
Screening for UV-sensitive DNA mutation sites as dosimeters for individual sun exposure, using high-fidelity Duplex Sequencing to reduce false positives and a stringent genome alignment protocol to reduce false negatives, revealed: (i) Sun-exposed human skin contained UV signature mutations (C -> T at a diypyrimidine) >1000-fold more frequently than unexposed neonatal skin, making these mutations sensitive genomic dosimeters for UV exposure. (ii) Tumor suppressor gene hotspot nucleotides (nt) reached variant allele frequency (VAF) 0.1%-10% via 30-3000 fold clonal expansion in occasional biopsies, due to being cancer drivers. (iii) Cyclobutane pyrimidine dimer (CPD) hyperhotspots attained those frequencies in nearly every biopsy, due to profuse creation plus similar to 30-fold clonal expansion. (iv) Neonatal keratinocyte cultures exposed to weeks of low-dose UVB exposure developed mutations at skin cancer tumor suppressor gene hotspot nt rarely and randomly, as expected. (v) CPD hyperhotspots in gene promoters acquired mutations in days at 1000-fold higher frequencies. Sun exposure is the strongest risk factor for skin cancer, so quantifiable UV signature mutations at CPD hyperhotspots in normal skin may make it technically feasible to identify individuals in need of monitoring to ensure early detection.